Equity · Healthcare
NVAX
NASDAQNovavax (NVAX)
The line runs 8.86 USD on 24 August through 7.49 USD on 20 November, on a scale from 6 to 14. Days the market did not trade hold the previous close, flat.
- Market cap
- 1.2B USD
- Revenue, year to Dec 2025
- 1.1B USD
- EPS, diluted, year to Dec 2025
- 2.58 USD
- 52-week range
- 6.22 USD – 12.85 USD
- Avg volume
- 442.0K
- Mentions, 30 days
- 2
as of Nov 20, 2026
Have Novavax (NVAX) insiders bought or sold shares recently?
NVAX's newest Form 4 filing is dated 20 June 2026: none in the last 90 days.
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 20 Jun 2026 | Rodgers Richard JDirector | Option exercise | 18,880 | |
| 20 Jun 2026 | King Rachel K.Director | Option exercise | 18,880 | |
| 20 Jun 2026 | DOUGLAS RICHARDDirector | Option exercise | 18,880 | |
| 20 Jun 2026 | MCGLYNN MARGARET GDirector | Option exercise | 18,880 | |
| 20 Jun 2026 | MOTT DAVID MDirector | Option exercise | 18,880 | |
| 20 Jun 2026 | Alton Gregg HDirector | Option exercise | 18,880 | |
| 25 Apr 2026 | Newton Charles W.Director | Option exercise | 9,520 | |
| 10 Mar 2026 | Shiver John W.Director | Option exercise | 7,947 | |
| 07 Mar 2026 | Kelly James PatrickEVP, CFO and Treasurer | Option exercise | 12,223 | |
| 07 Mar 2026 | Kelly James PatrickEVP, CFO and Treasurer | Tax withheld | 5,904 | 59K USD |
| 03 Mar 2026 | Kelly James PatrickEVP, CFO and Treasurer | Option exercise | 43,167 | |
| 03 Mar 2026 | Kelly James PatrickEVP, CFO and Treasurer | Tax withheld | 20,850 | 198K USD |
Showing the 12 most recent of 36 compensation filings in this window. The figures above count all of them.
Which funds hold Novavax (NVAX)?
10 of the 45 institutional funds we track reported a Novavax position for the quarter ended 30 Sep 2026 — a combined 214.1M USD; the latest of those filings landed 16 Nov 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| D. E. Shaw & Co. | Held (±25%) | 5,732,460 | 62.0M USD | +1.4% |
| Two Sigma Investments | Added | 5,512,174 | 59.6M USD | +34.7% |
| Coatue Management | Held (±25%) | 3,836,986 | 41.5M USD | |
| Citadel Advisors | Added | 2,783,375 | 30.1M USD | +64.2% |
| Millennium Management | Trimmed | 1,061,711 | 11.5M USD | −40.0% |
| Marshall Wace | Trimmed | 462,141 | 5.0M USD | −29.2% |
| Man Group | New position | 168,630 | 1.8M USD | |
| AQR Capital Management | Trimmed | 157,543 | 1.7M USD | −82.5% |
| Tudor Investment Corp | Trimmed | 47,514 | 514K USD | −62.1% |
| Renaissance Technologies | Trimmed | 43,200 | 467K USD | −91.4% |
What has been filed or recorded for Novavax (NVAX)?
The filings we hold for Novavax, newest first: 4 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 22 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 22 Oct 2026 | Fails to deliver | Shares failed to deliver | 35 shares | 385 USD notional · <0.001% of shares out |
| 15 Oct 2026 | Fails to deliver | Shares failed to deliver | 15,790 shares | 200K USD notional · 0.010% of shares out |
| 13 Oct 2026 | Fails to deliver | Shares failed to deliver | 119 shares | 2K USD notional · <0.001% of shares out |
| 09 Oct 2026 | Fails to deliver | Shares failed to deliver | 39,344 shares | 433K USD notional · 0.024% of shares out |
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS −0.19 USD | Revenue $68M |
| 30 Sep 2026 | Financials | Total assets | 888.0M USD | at period end |
| 30 Sep 2026 | Financials | Total equity | −216.9M USD | at period end |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS −0.32 USD | Revenue $57M |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS −0.06 USD | Revenue $140M |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS 2.58 USD | Revenue $1.12B |
| 31 Dec 2025 | Financials | Revenue | 1.1B USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | 440.3M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | 2.58 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS −1.25 USD | Revenue $70M |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS 0.62 USD | Revenue $239M |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS 2.93 USD | Revenue $667M |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −1.23 USD | Revenue $682M |
What is Reddit saying about Novavax (NVAX)?
Reddit mentioned NVAX 2 times in the 30 days to 21 November 2026, in 1 of the communities we track. All of them were scored for sentiment: 100% read bullish, 0% bearish and 0% neither. Reddit data updated 21 November 2026.
30-day window, Method
How do Reddit mentions of Novavax (NVAX) compare with its price?
Share ↗
Which subreddits are talking about Novavax (NVAX)?
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/wallstreetbets | 100% | 2 | +0.09 |
What do people ask about Novavax (NVAX)?
What did Novavax shares close at?7.49
Novavax closed at 7.49 USD on 20 Nov 2026, down 2.98% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Novavax’s market cap?1.2B
Novavax is worth 1.2B USD by market value as of 20 Nov 2026, which is the share price times the shares on issue from its SEC filings.
What is Novavax’s revenue?1.1B
Novavax reported revenue of 1.1B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Novavax insiders bought or sold shares recently?
No Novavax insider has filed a Form 4 in the last 90 days; the most recent filing we hold is dated 20 Jun 2026 (SEC Form 4). See Insiders
Which funds own Novavax?10 of 45
10 of the 45 funds we track reported a Novavax position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported positions were D. E. Shaw & Co., Two Sigma Investments and Coatue Management. See Funds
When did Novavax last report earnings?−0.19
Novavax last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −0.19 USD; no next date is announced in SEC filings yet. See Filings
What is Reddit saying about Novavax?0 mentions
Novavax was mentioned 0 times in the last 7 days across the finance subreddits we track, and 2 times over the trailing 30 days. Of the 2 mentions scored for sentiment, 100% read bullish and 0% bearish. That is a social signal, not investment advice. See Reddit

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings
- SEC filingAbout text: the company's latest annual report filed with the SEC (Business section), summarised in our own words